Skip to content

Comparison of the effect of Dexmedetomidine with or without Pregabalin as before surgery in tympanoplasty under Local Anaesthesia.

A Randomized Controlled Trial to compare the effect of Dexmedetomidine with or without Pregabalin as premedication for conscious sedation in tympanoplasty under Local Anaesthesia - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073720
Enrollment
90
Registered
2024-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dexmedetomidine with Pregabalin: one year four months Control Intervention1: Dexmedetomidine without Pregabalin: one year four months

Sponsors

Dr Ankit Batra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: AMERICAN SOCIETY OF ANESTHESIOLOGISTS(ASA) PHYSICAL STATUS CLASS 1 AND 2

Exclusion criteria

Exclusion criteria: 1. Patient refusal for Surgery. 2. Patient having Liver disorders. 3. Patient having Kidney disorders. 4. Patient having Cardiac and respiratory disease. 5. Patient having Morbid obesity. 6. Patient having allergy to the study drug.

Design outcomes

Primary

MeasureTime frame
Intraoperative and postoperative sedation score (by Modified Ramsay sedation score) between the two groups.Timepoint: Intraoperative vitals will be monitored after every 5 mins from the time of giving dexmedetomidine drug till 30 mins and then every 15 mins till 1 hour and then after every 30mins till 6 hours.

Secondary

MeasureTime frame
1.Intraoperative and postoperative analgesia (by VAS score) 2.intraoperative and postoperative hemodynamic parameters (HR, SBP, DBP, MBP). 3.intraoperative and postoperative side effects (hypotension, bradycardia, respiratory distress, nausea and vomiting).Timepoint: Intraoperative and postoperative score and vitals will be monitored after every 5 mins from the time of giving dexmedetomidine drug till 30 mins and then every 15 mins till 1 hour and then after every 30mins till 6 hours.

Countries

India

Contacts

Public ContactDr Jyoti Sharma

Maharaja agrasen medical college

dr.jyotiumesh@gmail.com8607672844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026